Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 07 April 2021
Increases in the projected incidence counts of key cancer types are in part attributable to the increasing and ageing population.
Published date 21 March 2021
In NSW, 5-year disease-specific survival was high (90%). Adjusted analyses indicated that advanced disease was more common in lower socioeconomic areas, with less breast reconstruction and radiotherapy, and marginally less hormone therapy for women from these areas.
Published date 19 March 2021
International comparisons were made difficult by wide differences in the proportion of tumors with unspecified histology, which accounted for up to 52% of diagnoses in children and up to 65% in adults.
Published date 04 March 2021
Men with prostate cancer were twice as likely to have radical prostatectomy as to receive external beam radiotherapy, and fewer than one in seven had consulted radiation oncologists prior to prostatectomy.
Published date 18 February 2021
There was evidence of aetiological heterogeneity for melanoma, supporting the dual pathway hypothesis. These findings enhance understanding of risk factors for melanoma and can guide prevention and skin examination education and practices.
Published date 17 February 2021
There is diversity in breast cancer extent of disease, treatment, and survival by country of birth.
Published date 27 January 2021
Source:
Sci Rep. 2021 Jan 27;11(1):2343
Factor analysis is an approach that can be used to identify associations between exposure patterns and cancer risk.
Published date 22 January 2021
Women aged ≥35 years are at increased risk of gestational breast cancer.
Published date 21 January 2021
There are differences in modelled versus observed surgery rates for some cancers, requiring more in-depth analysis of the observed differences.
Published date 21 January 2021
The global demand for cancer surgery and the optimal workforce are predicted to increase over the next two decades and disproportionately affect low-income countries.
